Alcuronium chloride

From WikiMD's WELLNESSPEDIA

Alcuronium chloride[edit]

Chemical structure of Alcuronium chloride
3D model of Alcuronium chloride

Alcuronium chloride is a neuromuscular-blocking drug used in anesthesia to induce muscle relaxation during surgery. It is a semi-synthetic compound derived from toxiferine, an alkaloid found in the plant Strychnos toxifera.

Pharmacology[edit]

Alcuronium chloride acts as a competitive antagonist at the nicotinic acetylcholine receptors located at the neuromuscular junction. By blocking the action of acetylcholine, it prevents depolarization of the muscle cell membrane, leading to muscle paralysis.

Mechanism of Action[edit]

The drug binds to the acetylcholine binding site on the nicotinic receptor, preventing acetylcholine from attaching and activating the receptor. This inhibition of receptor activation results in the inability of the muscle to contract, thus causing paralysis.

Pharmacokinetics[edit]

Alcuronium chloride is administered intravenously. It has a rapid onset of action and a duration of effect that is intermediate compared to other neuromuscular blockers. The drug is metabolized in the liver and excreted primarily through the kidneys.

Clinical Use[edit]

Alcuronium chloride is used as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Dosage and Administration[edit]

The dosage of alcuronium chloride is individualized based on the patient's response and the type of surgical procedure. It is typically administered as an intravenous bolus or continuous infusion.

Side Effects[edit]

Common side effects include hypotension, tachycardia, and histamine release. Rarely, it may cause anaphylaxis or prolonged neuromuscular blockade.

Contraindications[edit]

Alcuronium chloride is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with myasthenia gravis or other neuromuscular disorders.

Related pages[edit]

Gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.